Lipid Modifying Agent/ Antihyperlipidemic Agent Atorvastatin is indicated as an adjunct to diet for the treatment of patients with elevated total cholesterol, LDL-Cholesterol, apolipoprotein B and triglycerides and to increase HDL-cholesterol in patients with primary hypercholesterolemia, combined hyperlipidemia, elevated serum triglycerides levels, and for patients with dysbetalipoproteinemia who do not respond adequately to diet. Atorvastatin is also indicated for the reduction of total cholesterol and LDL-cholesterol in patients with homozygous familial hypercholesterolemia when response to diet and other non-pharmacological measures are inadequate.